Neurotechnology startup Phantom Neuro, Austin, Texas, announced a $6 million funding round led by new investor Time BioVentures. The round included participation from another new investor, Risk & Return, a venture fund focused on “capitalism for good.” Support from returning investors brings the company’s total funding to $9.5M.
D.A. Wallach co-founder of Time BioVentures, will join the Phantom Neuro board. The company also announced the addition of two key hires: Aurel Bouvier, PhD, vice president of implantable systems, and Erik Lloyd, senior neuroengineer.
Launched this year, Phantom Neuro combines low-risk implantable sensors, artificial intelligence, and enabling software to improve control of orthopedic technologies, including prosthetic limbs and exoskeletons.
“The field of advanced robotics has enormous potential to augment patients’ daily lives, and yet we lack practical and effective commercially available devices to control these systems outside of the lab. Phantom Neuro is filling this void by creating an elegant link between biology and prosthetics that has the potential to revolutionize the standard of care for patients” said Wallach. “Connor Glass, Phantom Neuro’s founder, brings to this challenge formidable talents as a physician, inventor, and company builder. We believe he and his growing team have what it takes to deliver real solutions to patients with urgency and creativity.”
